Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FD1BP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Xtandi 80 mg, a prescription oncology medication. The contract was awarded on September 15, 2025, with a ceiling value of $4,169.59 and an ultimate completion date of September 16, 2025. This delivery order operates under a firm fixed-price arrangement with no set-aside designation and represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with the DLA through its larger Indefinite Delivery Contract vehicle.
This award is issued under DMS Pharmaceutical Group's substantial single-award IDC with the DLA valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables the DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages this contract vehicle to deliver prescription medications, biologics, and medical consumables directly to military health installations, with this particular delivery order focusing on cancer treatment support.
Quick answers
Who was awarded contract SPE2DB25FD1BP?
SPE2DB25FD1BP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FD1BP worth?
The government has obligated $4,170 on SPE2DB25FD1BP.
Is contract SPE2DB25FD1BP an order under another contract?
Yes. SPE2DB25FD1BP is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FD1BP competed?
The extent of competition for SPE2DB25FD1BP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award